Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control
Open Access
- 30 May 2024
- journal article
- research article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 57 (3) , 309-316
Abstract
The treatment of obesity and its comorbidities ranges from clinical management involving lifestyle changes and medications to bariatric and metabolic surgery. Various endoscopic bariatric and metabolic therapies recently emerged to address an important therapeutic gap by offering a less invasive alternative to surgery that is more effective than conservative therapies. This article comprehensively reviews the technical aspects, mechanism of action, outcomes, and future perspectives of one of the most promising endoscopic bariatric and metabolic therapies, named duodenojejunal bypass liner. The duodenojejunal bypass liner mimics the mechanism of Roux-en-Y gastric bypass by preventing food contact with the duodenum and proximal jejunum, thereby initiating a series of hormonal changes that lead to delayed gastric emptying and malabsorptive effects. These physiological changes result in significant weight loss and improved metabolic control, leading to better glycemic levels, preventing dyslipidemia and non-alcoholic fatty liver disease, and mitigating cardiovascular risk. However, concern exists regarding the safety profile of this device due to the reported high rates of severe adverse events, particularly liver abscesses. Ongoing technical changes aiming to reduce adverse events are being evaluated in clinical trials and may provide more reliable data to support its routine use in clinical practice.Keywords
This publication has 42 references indexed in Scilit:
- Glycemic control and BMI changes after endoscopic implantation of a duodenojejunal bypass liner compared with laparoscopic Roux-en-Y gastric bypass surgery: a propensity score matching analysisSurgical Endoscopy, 2022
- Primary obesity surgery endoluminal (POSE) for the treatment of obesity: a systematic review and meta-analysisSurgical Endoscopy, 2021
- Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-AnalysisObesity Surgery, 2020
- Duodenal-Jejunal Bypass Liner (DJBL) Improves Cardiovascular Risk Biomarkers and Predicted 4-Year Risk of Major CV Events in Patients with Type 2 Diabetes and Metabolic SyndromeObesity Surgery, 2020
- Endoscopic Management of Anchor Erosion Adjacent to the Pylorus Following Duodenal-Jejunal Bypass SleeveObesity Surgery, 2019
- Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantationSurgical Endoscopy, 2019
- Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical TrialObesity Surgery, 2019
- Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic ReviewObesity Surgery, 2018
- Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic PatientsObesity Surgery, 2015
- Surgery for weight loss in adultsCochrane Database of Systematic Reviews, 2014